Unilateral Biportal Endoscopy Market By Product Type (Endoscope, Accessory Devices), By Indication (Herniated Discs, Spinal Stenosis, Others), By End User (Hospitals, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global unilateral biportal endoscopy market was valued at $295.31 million in 2021, and is projected to reach $548.43 million by 2031, registering a CAGR of 6.4% from 2022 to 2031. Unilateral biportal endoscopy (UBE) is a percutaneous endoscopic technique. It is performed through two separated small surgical incisions on either side of the spinous process. With continuous high-pressure normal saline irrigation and high-definition arthroscope, the surgeon can do very precise decompression in a clear and magnified surgical field. The advantage of the unilateral biportal endoscopic technique is that it provides a good view of the contralateral, sublaminar foraminal area without additional incision. In addition, there is less muscle dissection. The risk of infection is low and clear visualization and less intraoperative bleeding can be obtained due to continuous saline irrigation. However, the surgeon should understand the concept of triangulation and overcome a steep learning curve to perform this operation. Meningeal irritation can be caused by excessive saline irrigation after surgery.
The major factors that drive the growth of the global unilateral biportal endoscopy market include technological advancement and rise in adoption of minimal invasive procedures. In addition, surge in geriatric population and increase in government expenditure on healthcare propel the market growth. However, shortage of trained physician and endoscopists are likely to restrain the growth of the unilateral biportal endoscopy market during the forecast period. Conversely, booming healthcare sector in developing economies are anticipated to provide lucrative opportunities to the market players.
The unilateral biportal endoscopy market is segmented into product, indication, end user and region. According to product, the market is categorized into endoscope and accessory device. On the basis of indication, the market is classified into herniated discs, spinal stenosis, others. By end user, it is segregated into hospitals and clinics and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Endovision Co. Ltd., Karl Storz, Smith & Nephew, Stryker Corporation, CONMED Corporation, Maxer Endoscopy GmbH, Joimax GmbH, Richard Wolf, Jiangsu Bonss Medical Technology Co. Ltd., and Maxmorespine.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the unilateral biportal endoscopy market analysis from 2021 to 2031 to identify the prevailing unilateral biportal endoscopy market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the unilateral biportal endoscopy market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global unilateral biportal endoscopy market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
Endoscope
Accessory Devices
By Indication
Herniated Discs
Spinal Stenosis
Others
By End User
Hospitals
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
South Africa,
Saudi Arabia
Rest of LAMEA
Key Market Players
Endovision Co. Ltd.
Jiangsu Bonss Medical Technology Co. Ltd.
Joimax GmbH
Karl Storz
Kinetix Lifesciences
Maxer Endoscopy GmbH
Richard Wolf
Smith & Nephew
Stryker Corporation
CONMED Corporation
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook